These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 25689347)
1. Exploitation of the ability of γ-tocopherol to facilitate membrane co-localization of Akt and PHLPP1 to develop PHLPP1-targeted Akt inhibitors. Yan R; Chuang HC; Kapuriya N; Chou CC; Lai PT; Chang HW; Yang CN; Kulp SK; Chen CS J Med Chem; 2015 Mar; 58(5):2290-8. PubMed ID: 25689347 [TBL] [Abstract][Full Text] [Related]
2. Vitamin E facilitates the inactivation of the kinase Akt by the phosphatase PHLPP1. Huang PH; Chuang HC; Chou CC; Wang H; Lee SL; Yang HC; Chiu HC; Kapuriya N; Wang D; Kulp SK; Chen CS Sci Signal; 2013 Mar; 6(267):ra19. PubMed ID: 23512990 [TBL] [Abstract][Full Text] [Related]
3. Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt. Li X; Yang H; Liu J; Schmidt MD; Gao T EMBO Rep; 2011 Jun; 12(8):818-24. PubMed ID: 21701506 [TBL] [Abstract][Full Text] [Related]
4. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit. Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691 [TBL] [Abstract][Full Text] [Related]
5. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum. Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829 [TBL] [Abstract][Full Text] [Related]
6. Oncogenic suppression of PHLPP1 in human melanoma. Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273 [TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling Chern Y; Zhang P; Ju H; Tai IT Cancer Biol Med; 2020 May; 17(2):343-356. PubMed ID: 32587773 [No Abstract] [Full Text] [Related]
8. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt. Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620 [TBL] [Abstract][Full Text] [Related]
9. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599 [TBL] [Abstract][Full Text] [Related]
10. PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation. Yu Y; Dai M; Lu A; Yu E; Merlino G Oncogene; 2018 Apr; 37(17):2225-2236. PubMed ID: 29391600 [TBL] [Abstract][Full Text] [Related]
11. Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy. Moc C; Taylor AE; Chesini GP; Zambrano CM; Barlow MS; Zhang X; Gustafsson ÅB; Purcell NH Cardiovasc Res; 2015 Feb; 105(2):160-70. PubMed ID: 25411382 [TBL] [Abstract][Full Text] [Related]
12. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells. Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes. Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368 [TBL] [Abstract][Full Text] [Related]
15. Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression. Huang YS; Chang CC; Lee SS; Jou YS; Shih HM Oncotarget; 2016 Jul; 7(28):43256-43266. PubMed ID: 27248326 [TBL] [Abstract][Full Text] [Related]
16. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation. Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669 [TBL] [Abstract][Full Text] [Related]
17. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1). Gangula NR; Maddika S J Biol Chem; 2013 Nov; 288(48):34545-54. PubMed ID: 24145035 [TBL] [Abstract][Full Text] [Related]
18. Turning off AKT: PHLPP as a drug target. Newton AC; Trotman LC Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697 [TBL] [Abstract][Full Text] [Related]
19. Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation. Bradley EW; Carpio LR; Newton AC; Westendorf JJ J Biol Chem; 2015 Jun; 290(26):16272-80. PubMed ID: 25953896 [TBL] [Abstract][Full Text] [Related]
20. Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells. Suljagic M; Laurenti L; Tarnani M; Alam M; Malek SN; Efremov DG Leukemia; 2010 Dec; 24(12):2063-71. PubMed ID: 20861921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]